Successful therapy of retroperitoneal fibrosis due to IgG4-related disease with rituximab, cyclophosphamide and glucocorticoids followed by maintenance therapy wit ritutixmab
Vnitřní lékařství · 2023
DOI: 10.36290/vnl.2023.035 ↗Kurz gefasst
Fallbericht in der Zeitschrift Vnitřní lékařství, 2023. Verfasst von Zdeněk Adam und 10 weiteren Autor:innen. Hauptthemen laut MEDLINE: Immunoglobulin G4-Related Disease, Retroperitoneal Fibrosis. Die Arbeit nennt 99 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Adam, Z., Čermák, A., Petrášová, H., Řehák, Z., Koukalová, R., Fojtík, Z., Pour, L., Boichuk, I., Krejčí, M., Král, Z., & Benda, P. (2023). Successful therapy of retroperitoneal fibrosis due to IgG4-related disease with rituximab, cyclophosphamide and glucocorticoids followed by maintenance therapy wit ritutixmab. Vnitřní lékařství. https://doi.org/10.36290/vnl.2023.035
Vancouver
Adam Z, Čermák A, Petrášová H, Řehák Z, Koukalová R, Fojtík Z, et al. Successful therapy of retroperitoneal fibrosis due to IgG4-related disease with rituximab, cyclophosphamide and glucocorticoids followed by maintenance therapy wit ritutixmab. Vnitřní lékařství. 2023. doi:10.36290/vnl.2023.035
BibTeX
@article{Adam2023,
author = {Adam, Zdeněk and Čermák, Aleš and Petrášová, Hana and Řehák, Zdeněk and Koukalová, Renata and Fojtík, Zdeněk and Pour, Luděk and Boichuk, Ivanna and Krejčí, Marta and Král, Zdeněk and Benda, Petr},
title = {Successful therapy of retroperitoneal fibrosis due to IgG4-related disease with rituximab, cyclophosphamide and glucocorticoids followed by maintenance therapy wit ritutixmab},
journal = {Vnitřní lékařství},
year = {2023},
doi = {10.36290/vnl.2023.035}
}
EUVIMED